These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 15752253)

  • 1. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
    Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
    J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
    Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
    Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
    Yavuz S; Toker E; Bicakcigil M; Mumcu G; Cakir S
    J Rheumatol; 2006 Jul; 33(7):1289-92. PubMed ID: 16821267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome.
    Ben-Chetrit E; Fischel R; Rubinow A
    Clin Rheumatol; 1993 Dec; 12(4):471-4. PubMed ID: 8124907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
    Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
    Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary anti-spectrin autoantibodies in Sjögren's syndrome.
    Moody M; Zipp M; Al-Hashimi I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
    Deming FP; Al-Hashimi I; Haghighat N; Hallmon WW; Kerns DG; Abraham C; Rivera-Hidalgo F
    J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
    Hansen B; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
    Tishler M; Yaron I; Shirazi I; Yaron M
    J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
    Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
    J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of anti-Ro(SS-A) by using immunoimprint. Comparison with double diffusion in agar. Apropos of a series of 63 primary Gougerot-Sjögren syndromes].
    Meyer O; Haim T; Bourgeois P; Palazzo E; Ribard P; Belmatoug N; Kahn MF
    Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):149-55. PubMed ID: 1905419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
    Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
    Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
    Locht H; Pelck R; Manthorpe R
    J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
    Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
    Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.